{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:36:25Z","timestamp":1772775385736,"version":"3.50.1"},"reference-count":147,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1080\/13543784.2022.2030312","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T08:26:01Z","timestamp":1642494361000},"page":"173-192","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Novel investigational treatments for ventilator-associated pneumonia and critically ill patients in the intensive care unit"],"prefix":"10.1080","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4456-7220","authenticated-orcid":false,"given":"Rachael","family":"Cusack","sequence":"first","affiliation":[{"name":"Trinity College, Dublin","place":["Ireland"]},{"name":"St. James\u2019s Hospital","place":["Dublin, Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Garduno","sequence":"additional","affiliation":[{"name":"Trinity College, Dublin","place":["Ireland"]},{"name":"Trinity College Dublin","place":["Dublin, Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Elkholy","sequence":"additional","affiliation":[{"name":"St. James\u2019s Hospital","place":["Dublin, Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5834-4063","authenticated-orcid":false,"given":"Ignacio","family":"Mart\u00edn-Loeches","sequence":"additional","affiliation":[{"name":"Trinity College, Dublin","place":["Ireland"]},{"name":"St. James\u2019s Hospital","place":["Dublin, Ireland"]},{"name":"St. James\u2019s Hospital","place":["Dublin, Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2020.01.020"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202004-385OC"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/664049"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530080055041"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/0885066620952763"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1086\/663344"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1717295115"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2011.05.004"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00326-4"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/595011"},{"key":"e_1_3_3_13_1","unstructured":"European Centre for Disease Prevention and Control and European Medicines Agency The bacterial challenge: time to react: a call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents. LU: publications office 2009. cited 2021 Sep 22 [Online]. Available: https:\/\/data.europa.eu\/doi\/10.2900\/2518"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/533452"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-016-0199-4"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv339"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0480-6"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8020045"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2015.98"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2017.4872"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2019.04.001"},{"issue":"2","key":"e_1_3_3_22_1","first-page":"E52","article-title":"The continuing threat of methicillin-resistant staphylococcus aureus","volume":"8","author":"Gajd\u00e1cs M","year":"2019","unstructured":"Gajd\u00e1cs M. The continuing threat of methicillin-resistant staphylococcus aureus. Antibiot. Basel Switz 2019 May;8(2):p. E52.","journal-title":"Antibiot. Basel Switz"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051068"},{"key":"e_1_3_3_24_1","first-page":"65","article-title":"Bad bugs, no drugs 2002\u20132020: progress, challenges, and call to action","volume":"131","author":"Boucher HW","year":"2020","unstructured":"Boucher HW. Bad bugs, no drugs 2002\u20132020: progress, challenges, and call to action. Trans. Am. Clin. Climatol. Assoc., 2020 131 ;65\u201371.","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30753-3"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz530"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0000000000000535"},{"key":"e_1_3_3_28_1","unstructured":"\u2018zavicefta-epar-product-information_en.pdf\u2019 zavicefta-epar-product-information_en.pdf\u2019 . Accessed: Aug. 19 2021 Accessed 19 08 2021. Accessed https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/zavicefta-epar-product-information_en.pdf"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/CE.S40698"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.01.018"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00507-6"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.02.022"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","unstructured":"\u2018International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society.\u2019 https:\/\/erj.ersjournals.com\/content\/50\/3\/1700582 (cited Aug. 19 2021).","DOI":"10.1183\/13993003.00582-2017"},{"key":"e_1_3_3_34_1","unstructured":"\u2018Overview | pneumonia (hospital-acquired): antimicrobial prescribing | guidance | NICE.\u2019 https:\/\/www.nice.org.uk\/guidance\/ng139 (cited Aug. 19 2021)."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-017-0141-6"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw353"},{"key":"e_1_3_3_37_1","unstructured":"Anonymous \u2018Zerbaxa \u2019 European Medicines Agency Sep. 17 2018. [Online]. Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zerbaxa (cited 2021 Aug. 30"},{"key":"e_1_3_3_38_1","unstructured":"\u2018Drug approval package: brand name (generic name) NDA #\u2019. [Online]. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/206829Orig1s000TOC.cfm (cited 2021 Aug 30)."},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa095"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01350-17"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30403-7"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03091-2"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy578"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0851-9"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.02.018"},{"key":"e_1_3_3_46_1","unstructured":"Francisco EM \u2018Recarbrio\u2019 European Medicines Agency Dec. 10 2019. [Online]. Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/recarbrio (cited 2021 Sep. 02"},{"key":"e_1_3_3_47_1","unstructured":"\u2018recarbrio-epar-product-information_en.pdf\u2019. Accessed: Sep. 02 2021 Accessed 2 9 2021. Accessed: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/recarbrio-epar-product-information_en.pdf"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0438"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.02.021"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0214-1"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00405-x"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku524"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00414-18"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.08.004"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02019-15"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa511"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01432-20"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw593"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab067"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02146-18"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01484-18"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8010032"},{"key":"e_1_3_3_63_1","unstructured":"Venatorx Pharmaceuticals Inc. \u2018A phase 3 randomized double-blind active controlled noninferiority study evaluating the efficacy safety and tolerability of cefepime\/VNRX-5133 in adults with complicated urinary tract infections (cUTI) including acute pyelonephritis\u2019 clinicaltrials.gov clinical trial registration NCT03840148 Jun. 2021. cited 2021 Sep 21. [Online]. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03840148"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01468-20"},{"key":"e_1_3_3_65_1","unstructured":"Allecra \u2018A Phase 3 Randomized Double-blind study to evaluate the efficacy and safety of cefepime-AAI101 compared to piperacillin\/tazobactam in the treatment of complicated urinary tract infections including acute pyelonephritis. \u2019 clinicaltrials.gov Clinical trial registration NCT03687255 Mar. 2020.cited 2021 Sep 21. [Online]. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03687255"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv166"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02229-19"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106330"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02596-17"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01329-17"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1667229"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2018.07.015"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0418-z"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.11.005"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu219"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10020170"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa974"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0905-x"},{"issue":"3","key":"e_1_3_3_79_1","first-page":"iii19","article-title":"FOCUS 1: a randomized, double-blinded, multicentre, phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia","volume":"66","author":"File TM","year":"2011","unstructured":"File TM, Low, DE, Eckburg, PB et al, . FOCUS 1: a randomized, double-blinded, multicentre, phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. J Antimicrob Chemother. 2011 Apr;66(3):iii19\u201332.","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr097"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02755-15"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.08.012"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2015.1037228"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00093-17"},{"key":"e_1_3_3_85_1","unstructured":"Dimitrova EK \u2018Fetcroja\u2019 European Medicines Agency Feb. 24 2020. [Online]. Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/fetcroja (cited 2021 Sep. 14"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30796-9"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30731-3"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1410"},{"key":"e_1_3_3_89_1","unstructured":"\u2018Summary review plazomicin FDA approval\u2019. cited 2021 Sep 16. [Online]. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/210303Orig1s000SumR.pdf"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00572-10"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00099-14"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01989-17"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801467"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807634"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S44377"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab495"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-012-0434-3"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2013.45.1.62"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365540903443157"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01288-13"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00436-16"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02036-13"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.4237"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1029"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa071"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0352-7"},{"key":"e_1_3_3_107_1","unstructured":"Anonymous \u2018Sivextro \u2019 European Medicines Agency Sep. 17 2018. [Online]. Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/sivextro (cited 2021 Sep. 17"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.10.009"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03688-14"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab032"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000439"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0518-2"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-014-3557-0"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-090817-062535"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02530-19"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1894-8"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1919888117"},{"key":"e_1_3_3_118_1","unstructured":"Adaptive Phage Therapeutics Inc. \u2018Expanded access study of phage treatment in Covid-19 patients on anti-microbials for pneumonia or bacteremia\/septicemia due to a. baumannii p. aeruginosa or s. aureus\u2019 clinicaltrials.gov clinical trial registration NCT04636554 Feb. 2021. Accessed: 2021 Sep 20.[Online]. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04636554"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201904-0839LE"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-019-00125-0"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1086\/651135"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000799"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00461-20"},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01462-20"},{"key":"e_1_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1902754"},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.09.024"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120200"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061255"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2016.1168803"},{"key":"e_1_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01142-09"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2156-1"},{"key":"e_1_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02190-13"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.07.012"},{"key":"e_1_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000002824"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.04.011"},{"key":"e_1_3_3_136_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001570"},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.12.016"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.03.018"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05890-w"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30574-2"},{"key":"e_1_3_3_141_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000002752"},{"key":"e_1_3_3_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2021.06.004"},{"key":"e_1_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00440-18"},{"key":"e_1_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01359-z"},{"key":"e_1_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30427-2"},{"key":"e_1_3_3_146_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209158"},{"key":"e_1_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06588-8"},{"key":"e_1_3_3_148_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-006961"},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2022.1999804"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2022.2030312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:49:57Z","timestamp":1772772597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2022.2030312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":147,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1080\/13543784.2022.2030312"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2022.2030312","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-11-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}